schizophrenia

News and resources

Nov 19 2024

Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program – Yahoo Finance

by Clinical Editor

No Comments

Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program Yahoo Finance

Nov 19 2024

Multiple sclerosis drug may help with poor working memory

by Clinical Editor

No Comments

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health...

Nov 18 2024

63-Year-Old Schizophrenic Woman Missing in Culver City – MyNewsLA.com

by Clinical Editor

No Comments

63-Year-Old Schizophrenic Woman Missing in Culver City MyNewsLA.com

Nov 18 2024

FDA approves Cobenfy for adults with schizophrenia – Medical Xpress

by Clinical Editor

No Comments

FDA approves Cobenfy for adults with schizophrenia Medical Xpress

Nov 17 2024

Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ – Investor’s Business Daily

by Clinical Editor

No Comments

Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor’s Business Daily

Nov 17 2024

People Are Opening Up About What It’s Like To Have Schizophrenia, And It’s Incredibly Interesting

by Clinical Editor

No Comments

I recently came across this question on Quora: “What is it like to have schizophrenia?” The thread led me to many other related questions where people with schizophrenia shared their...

Nov 16 2024

Psychedelic use linked to higher risk of schizophrenia

by Clinical Editor

No Comments

Study links hallucinogen use to higher schizophrenia risk, highlighting the need for caution and informed decisions on psychedelic use.

Nov 16 2024

Taking drugs like LSD and ecstasy can increase your risk of schizophrenia, according to new study

by Clinical Editor

No Comments

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like Kristen Bell and Aaron Rodgers publicly sharing their experiences.

Nov 15 2024

3 Things to Know About Cobenfy, the New Schizophrenia Drug – Yale Medicine

by Clinical Editor

No Comments

3 Things to Know About Cobenfy, the New Schizophrenia Drug Yale Medicine

Nov 15 2024

FDA approves Cobenfy for adults with schizophrenia

by Clinical Editor

No Comments

The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.